摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-fluorophenylthio)acetaldehyde | 1248249-23-1

中文名称
——
中文别名
——
英文名称
2-(2-fluorophenylthio)acetaldehyde
英文别名
2-[(2-Fluorophenyl)sulfanyl]acetaldehyde;2-(2-fluorophenyl)sulfanylacetaldehyde
2-(2-fluorophenylthio)acetaldehyde化学式
CAS
1248249-23-1
化学式
C8H7FOS
mdl
——
分子量
170.207
InChiKey
NAMBKTHYVWKSKM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    42.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-氟苯硫酚盐酸potassium carbonate 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 生成 2-(2-fluorophenylthio)acetaldehyde
    参考文献:
    名称:
    2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
    摘要:
    这项发明涉及取代基为2-吡啶基的咪唑类化合物,它们是转化生长因子-β(TGF-β)类型I受体(ALK5)和/或激活素类型I受体(ALK4)的抑制剂,以及其制备方法和在医学中的应用,具体用于治疗和预防由这些受体介导的疾病状态。
    公开号:
    US08080568B1
点击查看最新优质反应信息

文献信息

  • 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS
    申请人:Kim Dae-Kee
    公开号:US20110319406A1
    公开(公告)日:2011-12-29
    This invention relates to 2-pyridyl substituted imidazoles which are inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.
    本发明涉及2-吡啶基取代咪唑类化合物,其为转化生长因子-β(TGF-β)类型I受体(ALK5)和/或激活素类型I受体(ALK4)的抑制剂,以及其制备方法和在医学上的应用,特别是用于治疗和预防由这些受体介导的疾病状态。
  • 2-Pyridyl substituted imidazoles as therapeutic Alk5 and/or Alk4 inhibitors
    申请人:Ewha University-Industry Collaboration Foundation
    公开号:EP2947081A1
    公开(公告)日:2015-11-25
    This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors.
    本发明涉及作为转化生长因子-β(TGF-β)Ⅰ型受体(ALK5)和/或激活素Ⅰ型受体(ALK4)抑制剂的 2-吡啶基取代的咪唑(I)、其制备方法及其在医学中的用途,特别是在治疗和预防由这些受体介导的疾病状态中的用途。
  • Bi-functional complexes and methods for making and using such complexes
    申请人:Gouliaev Alex Haahr
    公开号:US11225655B2
    公开(公告)日:2022-01-18
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
    本发明涉及一种合成双功能复合物的方法,该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行,此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接,合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
  • BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Nuevolution A/S
    公开号:EP2558577A1
    公开(公告)日:2013-02-20
  • BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Gouliaev Alex Haahr
    公开号:US20130281324A1
    公开(公告)日:2013-10-24
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
查看更多